This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Orion OYJ (ORINY) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Orion OYJ (ORINY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
The Zacks Analyst Blog Highlights Assurant, Maplebear and Orion OYJ
by Zacks Equity Research
Assurant, Maplebear and Orion OYJ are part of the Zacks top Analyst Blog.
U.S. August Jobs Numbers Dominate: Global Week Ahead
by John Blank
In the Global Week Ahead, U.S. jobs numbers dominate the agenda, as markets brace for a choppy September.
3 Reasons Why Growth Investors Shouldn't Overlook Orion OYJ (ORINY)
by Zacks Equity Research
Orion OYJ (ORINY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Is Orion OYJ (ORINY) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Orion OYJ (ORINY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
GRFS or ORINY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GRFS vs. ORINY: Which Stock Is the Better Value Option?
CTLT or ORINY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CTLT vs. ORINY: Which Stock Is the Better Value Option?
Small Drug Stocks Near-Term Outlook Positive, Despite Headwinds
by Zacks Equity Research
Small drugmakers, in general, are having a decent year, despite failures of key pipeline candidates in pivotal studies.